4basebio | Retail Offer
Applications Open
515 pence per share
Offer Closes: 11am Wednesday 21 October
Important information - We do not offer advice on the suitability of any Retail Offers for you. Like any investment, there are risks and it is vital that you have all the information you need to make an informed decision. If you have any doubts about its suitability, seek financial advice. The value of investments can fall as well as rise, so you may get back less than you invest. Dividends are not guaranteed and, if paid, are variable. Any decision to invest into a Retail Offer should be done solely on the basis of the information provided in the Company Announcement and any other supplementary documentation.
About 4basebio
4basebio have announced their intention to raise a minimum of £15.5m via a Placing & Subscription for institutional investors and a Retail Offer for individual investors.
4basebio is a UK biotechnology company focused on synthetic DNA used in applications such as gene therapies, genome editing, mRNA therapies and vaccines. The company develops synthetic DNA manufacturing and non-viral nucleic acid delivery technologies for advanced therapies.
Use of Proceeds
The Company intends to use the proceeds of the capital raise to support commercial development, complete the fit-out of its Q-Arc facility, advance research and development activities, and provide additional working capital. Following completion of the fundraise, 4basebio expects to have sufficient funding through to H2 2028.
Further information about 4basebio and the fundraising can be found in the Company Announcement.
Ready to apply?
Make sure you've read these key documents.
What’s the expected timeline?
Applications might close early, without prior warning. If you’d like to take part, we’d suggest doing your research and completing your application in good time ahead of the deadline.
| 11am Wednesday 21 October | HL applications close |
| Thursday 22 October | Allocations confirmed by Secure Message |
| Friday 06 November | General Meeting |
| Tuesday 10 November | Shares credited to accounts |
Offer Details
Offer price: 515 pence representing a discount of 8.4% to the closing mid-price of the Company's existing shares on 14 October 2026.
Fundraising method: Long-dated. Please note that applications can close early and without prior warning.
Minimum investment: £100
Applications close: 11am Wednesday 21 October
Applications are open to existing shareholders only
Once applications have closed, you will not be able to amend or cancel your order
It’s free to apply for shares. Find out more about our charges.
What happens after you apply?
You can view or cancel your application in the ‘Pending Orders’ tab of your online account during the offer period.
You will receive confirmation of your allocation by Secure Message on Thursday 22 October
Shares are expected to be credited to your account on Tuesday 10 November 2026.
Important Information
Investing in an individual company isn’t right for everyone because if that company fails, you could lose your whole investment. If you cannot afford this, investing in a single company might not be right for you. You should make sure you understand the companies you’re investing in and their specific risks. You should also make sure any shares you own are part of a diversified portfolio.
The offer is only open to individuals who are physically located in the United Kingdom.
If the offer is oversubscribed, you may not receive the full amount that you have applied for.
Any cash not used to fund your allocation will be released back to your available balance when your allocated shares are credited to your account.
Your application will be accepted on the basis of information in the Company Announcement, HL Retail Offer Terms & Conditions and HL Risk Warning. If you are unsure whether an investment is suitable for you please seek Financial Advice.
The Retail Offer is conditional on the requisite approvals being obtained from shareholders at the general meeting of the Company expected to be held on or around 06 November 2026.
HL will receive a distribution fee to cover our costs of advertising this offer. This fee will not exceed 0.6% of the value of the shares allocated and is paid by 4basebio. You will not be charged to participate in this offer.
Costs & Charges
The following charges are based on an investment of £5,000 within a Stocks and Shares ISA over 5 years assuming 5% annual growth rate.
| HL charges | £105.21 |
| Investment charges | £0.00 |
| Total charges | £105.21 |
| Average annual charge | 0.37% |
| Illustrative value | £6,263.91 |
| Illustrative value with no charges applied | £6,381.41 |
The costs and charges shown are for illustration purposes only based on the assumptions presented. Please refer to our tariff of charges before investing. Returns are not guaranteed.
Figures may not add up to the given total due to rounding.